Search research articles
Contact Us
Filters
Showing results (1-10 of 183) with videos related to
Page
of 19
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
January 11, 2011
Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers
Prakash Deedwania
Indian Heart Journal
|
September 5, 2009
Contemporary approaches for cardiovascular risk reduction in diabetes
Prakash Deedwania
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 30, 2021
SGLT2 Inhibitors: The Dawn of a New Era in Cardio-Metabolic Therapeutics
Prakash Deedwania
Journal of the American Heart Association
|
October 30, 2018
The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease
Prakash Deedwania
Journal of the American College of Cardiology
|
March 19, 2013
Diabetes, cardiovascular disease, and ethnicity
Prakash Deedwania
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 6, 2007
Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients
Prakash Deedwania
Evidence-Based Cardiovascular Medicine
|
December 29, 2005
Intensive lipid-lowering is no more effective than diet and low-dose lovastatin for reducing ischaemia in people with heart disease. Commentary
Prakash Deedwania
Cardiology Clinics
|
January 25, 2011
Preface cardiovascular disease prevention: the continuum of primary and secondary prevention
Prakash Deedwania
Journal of the American College of Cardiology
|
October 6, 2018
Dangers of Hypoglycemia in Cardiac Patients With Diabetes: Time to Switch to Safer, Newer Drugs
Prakash Deedwania
Progress in Cardiovascular Diseases
|
August 31, 2019
Emerging strategies for diabetes and cardiovascular disorders: Introduction and foreword
Prakash Deedwania
Page
of 19
Search research articles
Search
Showing results (1-10 of 183) with videos related to
Sort By:
Page
of 19
Journal of Clinical Hypertension (Greenwich, Conn.)
|
January 11, 2011
Hypertension, dyslipidemia, and insulin resistance in patients with diabetes mellitus or the cardiometabolic syndrome: benefits of vasodilating β-blockers
Prakash Deedwania
Indian Heart Journal
|
September 5, 2009
Contemporary approaches for cardiovascular risk reduction in diabetes
Prakash Deedwania
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 30, 2021
SGLT2 Inhibitors: The Dawn of a New Era in Cardio-Metabolic Therapeutics
Prakash Deedwania
Journal of the American Heart Association
|
October 30, 2018
The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease
Prakash Deedwania
Journal of the American College of Cardiology
|
March 19, 2013
Diabetes, cardiovascular disease, and ethnicity
Prakash Deedwania
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 6, 2007
Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients
Prakash Deedwania
Evidence-Based Cardiovascular Medicine
|
December 29, 2005
Intensive lipid-lowering is no more effective than diet and low-dose lovastatin for reducing ischaemia in people with heart disease. Commentary
Prakash Deedwania
Cardiology Clinics
|
January 25, 2011
Preface cardiovascular disease prevention: the continuum of primary and secondary prevention
Prakash Deedwania
Journal of the American College of Cardiology
|
October 6, 2018
Dangers of Hypoglycemia in Cardiac Patients With Diabetes: Time to Switch to Safer, Newer Drugs
Prakash Deedwania
Progress in Cardiovascular Diseases
|
August 31, 2019
Emerging strategies for diabetes and cardiovascular disorders: Introduction and foreword
Prakash Deedwania
Page
of 19